| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Chief Medical Officer | Common Stock, par value $0.001 per share | 0 | $0 | $23.46 | Jun 2, 2025 | Direct |
| CATALYST PHARMACEUTICALS, INC. | Chief Medical Officer | Restricted Stock Units | 268K | Nov 20, 2025 | Direct | ||
| CATALYST PHARMACEUTICALS, INC. | Chief Medical Officer | Options to purchase common stock | 238K | Nov 20, 2025 | Direct | ||
| Flexion Therapeutics Inc | Chief Medical Officer | Common Stock | 0 | $8.50 | Nov 19, 2021 | Direct | |
| Flexion Therapeutics Inc | Chief Medical Officer | Stock option (right to buy) | 0 | Nov 19, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CPRX | CATALYST PHARMACEUTICALS, INC. | Nov 20, 2025 | 2 | $0 | 4 | Nov 24, 2025 | Chief Medical Officer |
| CPRX | CATALYST PHARMACEUTICALS, INC. | Jun 2, 2025 | 0 | $0 | 3 | Jun 6, 2025 | Chief Medical Officer |
| FLXN | Flexion Therapeutics Inc | Nov 19, 2021 | 2 | -$291K | 4 | Nov 19, 2021 | Chief Medical Officer |
| FLXN | Flexion Therapeutics Inc | Aug 2, 2021 | 2 | $0 | 4 | Aug 4, 2021 | Chief Medical Officer |
| FLXN | Flexion Therapeutics Inc | Jul 1, 2021 | 0 | $0 | 3 | Jul 6, 2021 | Chief Medical Officer |